The European and American guidelines on dyslipidemia management overlap but also diverge in critical ways. A Johns Hopkins cardiologist highlights similarities and differences.
Fewer Than 1 in 4 Women Maintain Optimal CV Health in Menopause: Daily Dose
Your daily dose of the clinical news you may have missed.
The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment
Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.
RDX-002 Hits Primary and Secondary End Points for Post–GLP-1 Weight Management
RDX-002, an investigational, first-in-class therapeutic, significantly reduced weight regain after cessation of antiobesity treatment with semaglutide and tirzepatide.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Excess Intake of Ultraprocessed Foods is Tied to Higher Cardiometabolic Risk, AHA Advisory Panel Says
The Advisory Panel laid out 4 priority actions for clinicians, policy makers, and industry.
FDA Approves Finerenone for Treatment of Heart Failure With LVEF ≥40%: Daily Dose